1-3 of 3
Authors: João Pedro Ferreira
Sort by
Journal Article
Response to Letter to Editor From Banerjee et al: “Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure”
João Pedro Ferreira and João Sérgio Neves
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 2, February 2024, Page e875, https://doi.org/10.1210/clinem/dgad507
Published: 25 August 2023
Journal Article
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure
João Pedro Ferreira and others
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 1, January 2024, Pages 4–9, https://doi.org/10.1210/clinem/dgad398
Published: 06 July 2023
Journal Article
Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
Priyadarshini Balasubramanian and others
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 7, July 2022, Pages e3003–e3007, https://doi.org/10.1210/clinem/dgac154
Published: 15 March 2022
Advertisement
Advertisement